Electronic Monitoring of Medication Adherence in Moderate to Severe Asthma
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Asthma
- Sponsor
- Montefiore Medical Center
- Enrollment
- 81
- Locations
- 1
- Primary Endpoint
- Asthma Control Test
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
This study will evaluate the role of using electronic sensors for asthma inhaler devices in monitoring medication adherence and asthma control
Detailed Description
This study will assess the feasibility of using electronic sensors for asthma inhalers in a population of urban minority adults and children with moderate-severe asthma in the Bronx. Investigators will also assess differences in asthma outcomes (specifically asthma control as a primary outcome measure) and treatment adherence in a group of participants with moderate-severe asthma who use inhalers with electronic sensors and real-time remote outreach worker monitoring/feedback compared to a group of participants who use inhalers with electronic sensors but without real-time monitoring/feedback.
Investigators
Marina Reznik
Associate Professor of Pediatrics
Montefiore Medical Center
Eligibility Criteria
Inclusion Criteria
- •Adults (\>18 years) and children (5-11 years old) with a clinical history (i.e. physician-diagnosed) of asthma
- •Moderate to severe asthmatics with ≥1 asthma-related ED visits or hospitalizations in the past year
- •Use of daily controller inhaler medications
- •Adult non-smokers, or lifetime use \<5 pack years with no smoking in last 1 yr
- •Smartphone required
- •English or Spanish speaking
Exclusion Criteria
- •No smartphone
- •Use of oral corticosteroids in prior 4 weeks
- •Pregnancy
- •Psychiatric conditions
Outcomes
Primary Outcomes
Asthma Control Test
Time Frame: change from baseline to 6 months
validated asthma control measure
Secondary Outcomes
- Medication adherence(change from baseline to 6 months)
- Health care utilization(change from baseline to 6 months)